Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07166822 · ClinicalTrials.gov registry record · NA

The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy

A NA study of Exercise and Cardiovascular (CV) Risk, sponsored by Old Dominion University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07166822: Recruiting NA study of Exercise and Cardiovascular (CV) Risk, sponsored by Old Dominion University.

NCT07166822 is a NA study of Exercise and Cardiovascular (CV) Risk that is actively recruiting participants, run by Old Dominion University. The registered enrollment target is 50 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07166822, a NA study of Exercise and Cardiovascular (CV) Risk, is actively recruiting participants, sponsored by Old Dominion University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine the effectiveness of a mobile exercise app in improving cardiovascular health and motivation to exercise in pregnant women who are healthy, in their 2nd trimester, between 18-45 years age, and do not do exercise currently. The aims of this study are determine i) the effect of a mobile app (BumptUp) to increase motivation to exercise as assessed by questionnaire, and ii) the changes may occur in cardiovascular health outcomes such as increased percent Flow-Mediated Dilation (FMD), Heart Rate Variability (HRV), and decreased Pulse Wave Velocity (PWV) over an 8-week period of intervention. Researchers will compare this to pregnant women who are healthy, in their 2nd trimester, between 18-45 years age, and who will not be using the mobile app (BumptUp) for exercise. Participants who are in the experimental group will be given access to the mobile app (BumptUp) for 8 weeks. Both the control and experimental group will visit the lab for their baseline measurements (study visit 1), followed by two visits at 4 weeks (study visit 2) and 8 weeks (study visit 3) to have their heart rate variability, arterial stiffness (PWV), and vascular function (FMD) assessed. At each study visit, blood pressure, heart rate, height, and weight will also be measured. Additionally, at all three study visits, participants will fill out a questionnaire to determine motivation to exercise.

Primary Outcome

The cardiovascular health via flow mediated dilation (% change from baseline) will be assessed

Interventions

  • BEHAVIORAL Experimental group using BumptUp mobile exercise app

Study Locations (1)

Virginia

  • Old Dominion University - Norfolk

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-09-15
Est. Completion 2028-08-01
Phase NA
Old Dominion University

23 total trials

What NCT07166822 shows while recruiting

NCT07166822 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Exercise appearing as the primary indexed condition, and to 1 intervention - of which Experimental group using BumptUp mobile exercise app is the first listed.

NCT07166822 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT07166822 about?

NCT07166822 is a clinical study titled "The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy". The goal of this study is to determine the effectiveness of a mobile exercise app in improving cardiovascular health and motivation to exercise in pregnant women who are healthy, in their 2nd trimester, between 18-45 years age, and do not do exercise currently. The aims of this study are determine i...

What is the current status of trial NCT07166822?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-15. Estimated completion is 2028-08-01.

What conditions does trial NCT07166822 study?

This clinical trial studies the following conditions: Exercise, Cardiovascular (CV) Risk.

What interventions are being tested in trial NCT07166822?

The interventions under investigation include: Experimental group using BumptUp mobile exercise app (BEHAVIORAL).

Who is sponsoring clinical trial NCT07166822?

This trial is sponsored by Old Dominion University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07166822 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07166822's enrollment target sits among peer trials

50 29th of 57 higher than 26 of 57 other Exercise trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Exercise trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07166822, the US trial registry maintained by the National Library of Medicine. NCT07166822 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.